Elevidys

Pharma

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Sarepta has suspended giving Elevidys to non-ambulatory DMD patients in the commercial setting while it seeks FDA approval of a risk mitigation plan.

Angus Liu Jun 16, 2025 10:58am

Collage poster study of businessmen picture chart arrow goes up

Novartis, Sarepta tipped to drive genomic therapy sales boom

May 15, 2025 12:18pm

pause button on blue background

Sarepta sees delays in treatment after Elevidys death report

May 7, 2025 8:03am

sarepta building

Sarepta, Roche halt 3 trials in Europe of gene therapy Elevidys

Apr 3, 2025 11:06am

thunderstorm road

Patient dies after receiving Sarepta's DMD gene therapy Elevidys

Mar 18, 2025 10:34am

Sarepta Sarepta Therapeutics

Sarepta's Elevidys blows sales expectations out of the water

Nov 7, 2024 3:43pm